第 1 到 72 筆結果,共 72 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer | YEN-TING LIN ; CHAO-CHI HO ; Hsu, Wei-Hsun; WEI-YU LIAO ; CHING-YAO YANG ; CHONG-JEN YU ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; SHANG-GIN WU ; CHIA-LIN HSU ; Hsieh, Min-Shu; YEN-LIN HUANG ; Wu, Chia-Ling; JIN-YUAN SHIH | Cancer medicine | 0 | ||
2 | 2023 | Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system | CHING-YAO YANG ; JIN-YUAN SHIH ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; TZU-HSIU TSAI ; SHANG-GIN WU ; YEN-TING LIN ; Hsu, Wei-Hsun; Jain, Suyog; Olsen, Steve; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | European journal of cancer (Oxford, England : 1990) | 0 | 0 | |
3 | 2023 | Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients | SHENG-KAI LIANG ; Wu, Chang-Wei; Chang, Ching-I; LI-TA KENG ; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU | Cancer medicine | 0 | 0 | |
4 | 2023 | Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors | CHUN-TA HUANG ; Lin, Chih-An; Su, Te-Jen; CHING-YAO YANG ; TZU-HSIU TSAI ; CHIA-LIN HSU ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU | BMC cancer | 5 | 2 | |
5 | 2023 | A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts | Pan, Huei-Jyuan; Lee, Chia-Wei; Wu, Li-Yu; Hsu, Heng-Hua; Tung, Yi-Chung; WEI-YU LIAO ; Lee, Chau-Hwang | APL bioengineering | 1 | 1 | |
6 | 2022 | Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma | CHIA-LING CHANG ; MIN-SHU HSIEH ; JIN-YUAN SHIH ; Lee, Yi-Hsuan; WEI-YU LIAO ; CHIA-LIN HSU ; CHING-YAO YANG ; KUAN-YU CHEN ; JIH-HSIANG LEE ; CHAO-CHI HO ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; CHONG-JEN YU | Therapeutic advances in medical oncology | 1 | 1 | |
7 | 2021 | Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | CHIA-LIN HSU ; TZU-HSIU TSAI ; CHUN-KAI HUANG ; CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; SHENG-YUAN RUAN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung cancer (Amsterdam, Netherlands) | 5 | 5 | |
8 | 2021 | Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan | SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | JTO Clinical and Research Reports | 16 | 0 | |
9 | 2021 | Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC | BIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG | JTO clinical and research reports | 2 | 0 | |
10 | 2021 | The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study | Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO ; YEN-TING LIN ; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 3 | 2 | |
11 | 2020 | Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer | Cho S.-L.; WEI-CHOU LIN ; Chuang C.-A.; WEI-YU LIAO ; CHUN-FU LAI | Nephrology | 0 | 0 | |
12 | 2020 | Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer | Hsu C.-C.; BIN-CHI LIAO ; WEI-YU LIAO ; Markovets A.; Stetson D.; Thress K.; CHIH-HSIN YANG | Journal of Thoracic Oncology | 56 | 44 | |
13 | 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 15 | 15 | |
14 | 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 55 | 49 | |
15 | 2020 | Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells | HSIN-HAN HOU ; Pan, Huei-Jyuan; WEI-YU LIAO ; Lee, Chau-Hwang; CHONG-JEN YU | International Journal of Cancer | 14 | 14 | |
16 | 2019 | Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; CHIA-CHI LIN ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 27 | 24 | |
17 | 2019 | Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma | Yang C.-Y.; MIN-SHU HSIEH ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Oncology Practice | 0 | 0 | |
18 | 2019 | Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations | YEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | International Journal of Cancer | 53 | 46 | |
19 | 2019 | Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors | JIH-HSIANG LEE ; Chen H.-Y.; Feng-Ming Hsu ; JIN-SHING CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIH-HSIN YANG | Oncologist | 20 | 18 | |
20 | 2018 | Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program | Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; JIN-YUAN SHIH ; WEI-YU LIAO ; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; CHIH-HSIN YANG ; Lorence, Robert M; Carrière, Philippe; Cseh, Agnieszka; Chang, Gee-Chen | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 65 | 57 | |
21 | 2018 | Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study | SHENG-KAI LIANG ; MENG-RUI LEE ; WEI-YU LIAO ; CHAO-CHI HO ; JEN-CHUNG KO ; JIN-YUAN SHIH | Oncotarget | 17 | 0 | |
22 | 2018 | Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery | WEN-CHI YANG ; FU-REN XIAO ; JIN-YUAN SHIH ; CHAO-CHI HO ; YA-FANG CHEN ; Tseng H.-M.; KUAN-YU CHEN ; WEI-YU LIAO ; CHONG-JEN YU ; CHIH-HSIN YANG ; SUNG-HSIN KUO ; CHIA-HSIEN CHENG ; PAN-CHYR YANG ; FENG-MING HSU | Radiotherapy and Oncology | 22 | 21 | |
23 | 2018 | Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study | Liao Y.-C.; WEI-YU LIAO ; Sun J.-L.; JEN-CHANG KO ; CHONG-JEN YU | Supportive Care in Cancer | 22 | 18 | |
24 | 2018 | Cigarette smoke extract enhances the invasion of lung cancer cells co-cultured with fibroblasts in 3D cellular spheroids | Pan H.-J.; HSIN-HAN HOU ; Hung Y.-C.; WEI-YU LIAO ; CHONG-JEN YU ; Lee C.-H. | 22nd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2018 | 0 | ||
25 | 2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
26 | 2018 | Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients | Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE ; CHIA-CHI LIN ; WEI-YU LIAO ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG | Clinical Lung Cancer | 16 | 17 | |
27 | 2018 | Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer | YUN-HSIANG LEE ; Liao Y.-C.; Shun S.-C.; Lin K.-C.; WEI-YU LIAO ; Chang P.-H.; Jhang S.-Y.; CHONG-JEN YU ; PAN-CHYR YANG ; Hsieh P.-Y.; YEUR-HUR LAI | Psycho-Oncology | 30 | 29 | |
28 | 2018 | Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan | SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Journal of Cancer | 40 | 41 | |
29 | 2018 | Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum | WEI-YU LIAO ; CHAO-CHI HO ; TZU-HSIU TSAI ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Lung Cancer | 14 | 11 | |
30 | 2018 | The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer | KAI-LUN YU ; TZU-HSIU TSAI ; CHAO-CHI HO ; WEI-YU LIAO ; CHING-KAI LIN ; CHIA-LIN HSU ; JIN-YUAN SHIH | Scientific Reports | 12 | 10 | |
31 | 2017 | Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study | Chang G.-C.; Tseng C.-H.; Hsu K.-H.; CHONG-JEN YU ; Yang C.-T.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Liu C.-Y.; WEI-YU LIAO ; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; Tsai Y.-H.; Hsieh M.-J.; Wu W.-S.; Chen Y.-M. | Lung Cancer | 22 | 18 | |
32 | 2017 | Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib | CHAO-CHI HO ; WEI-YU LIAO ; Lin C.-A.; JIN-YUAN SHIH ; CHONG-JEN YU ; Chih-Hsin CHIH-HSIN YANG | Journal of Thoracic Oncology | 179 | 164 | |
33 | 2017 | Elevated hydrostatic pressure enhances the motility and enlarges the size of the lung cancer cells through aquaporin upregulation mediated by caveolin-1 and ERK1/2 signaling | Kao, Y.-C.; Jheng, J.-R.; Pan, H.-J.; WEI-YU LIAO ; Lee, C.-H.; PO-LING KUO | Oncogene | 32 | 29 | |
34 | 2017 | Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; Chia-Chi Lin ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 25 | 25 | |
35 | 2016 | The unmet supportive care needs—what advanced lung cancer patients’ caregivers need and related factors | Chen S.-C.; Chiou S.-C.; CHONG-JEN YU ; YUN-HSIANG LEE ; WEI-YU LIAO ; Hsieh P.-Y.; Jhang S.-Y.; YEUR-HUR LAI | Supportive Care in Cancer | 60 | 55 | |
36 | 2016 | Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis | Chen L.-Y.; Molina-Vila M.A ; SHENG-YUAN RUAN ; KANG-YI SU ; WEI-YU LIAO ; KAI-LUN YU ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; Rosell R.; PAN-CHYR YANG | Lung Cancer | 57 | 52 | |
37 | 2016 | Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases | Lin C.-H.; SONG-CHOU HSIEH ; LI-TA KENG ; Lee H.-S.; Chang H.-T.; WEI-YU LIAO ; CHAO-CHI HO ; CHONG-JEN YU | PLoS ONE | 6 | 5 | |
38 | 2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
39 | 2015 | Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib | Gow C.-H.; WEI-YU LIAO ; Liu Y.-N.; JIN-YUAN SHIH | Journal of Thoracic Oncology | 14 | 14 | |
40 | 2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
41 | 2015 | Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer | WEI-YU LIAO ; CHAO-CHI HO ; HSIN-HAN HOU ; Hsu T.-H.; Tsai M.-F.; KUAN-YU CHEN ; Chen H.-Y.; Lee Y.-C.; CHONG-JEN YU ; Lee C.-H.; PAN-CHYR YANG | Journal of Pathology | 23 | 20 | |
42 | 2015 | GM2-activator protein: A new biomarker for lung cancer | Potprommanee L.; Ma H.-T.; Shank L.; Juan Y.-H.; WEI-YU LIAO ; Chen S.-T.; CHONG-JEN YU | Journal of Thoracic Oncology | 18 | 16 | |
43 | 2014 | Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer | JIH-HSIANG LEE ; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; YEUN-CHUNG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIA-CHI LIN ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
44 | 2014 | Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study | Liao Y.-C.; Shun S.-C.; WEI-YU LIAO ; CHONG-JEN YU ; PAN-CHYR YANG ; YEUR-HUR LAI | Oncology Nursing Forum | 39 | 39 | |
45 | 2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma | Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; CHONG-JEN YU ; WEI-YU LIAO ; Tsai, Chi-Ren; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy Jw; Chen, Hsuan-Yu; MONG-HSUN TSAI | OncoTargets and Therapy | 15 | 14 | |
46 | 2014 | Modulating chemotaxis of lung cancer cells by using electric fields in a microfluidic device | Kao Y.-C.; Hsieh M.-H.; Liu C.-C.; Pan H.-J.; WEI-YU LIAO ; Cheng J.-Y.; Kuo P.-L.; Lee C.-H. | Biomicrofluidics | 13 | 13 | |
47 | 2013 | Interaction between lung cancer cell and myofibroblast influenced by cyclic tensile strain | Huang J.-W.; Pan H.-J.; Yao W.-Y.; Tsao Y.-W.; WEI-YU LIAO ; Wu C.-W.; Tung Y.-C.; Lee C.-H. | Lab on a Chip | 17 | 16 | |
48 | 2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
49 | 2013 | Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatment | YUN-HSIANG LEE ; Liao Y.-C.; WEI-YU LIAO ; Shun S.-C.; Liu Y.-C.; Chan J.-C.; CHONG-JEN YU ; PAN-CHYR YANG ; YEUR-HUR LAI | Psycho-Oncology | 45 | 36 | |
50 | 2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
51 | 2013 | Survival of lung adenocarcinoma patients with malignant pleural effusion | SHANG-GIN WU ; CHONG-JEN YU ; Tsai M.-F.; WEI-YU LIAO ; CHIH-HSIN YANG ; I-SHIOW JAN ; PAN-CHYR YANG ; JIN-YUAN SHIH | European Respiratory Journal | 86 | 77 | |
52 | 2012 | The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chip | Hsu, T.-H.; Kao, Y.-L.; Lin, W.-L.; Xiao, J.-L.; Kuo, P.-L.; Wu, C.-W.; WEI-YU LIAO ; PO-LING KUO | Integrative Biology | 39 | 39 | |
53 | 2012 | Endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: How many specimens are necessary? | CHUN-TA HUANG ; Tsai Y.-J.; WEI-YU LIAO ; Wu P.-C.; CHAO-CHI HO ; CHONG-JEN YU ; PAN-CHYR YANG | Respiration | 21 | 21 | |
54 | 2012 | Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions | CHUN-TA HUANG ; SHENG-YUAN RUAN ; WEI-YU LIAO ; YAO-WEN KUO ; Lin C.-Y.; Tsai Y.-J.; CHAO-CHI HO ; CHONG-JEN YU | PLoS ONE | 26 | 25 | |
55 | 2012 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum | WEI-YU LIAO ; JIN-YUAN SHIH ; Chang G.-C.; Cheng Y.-K.; CHIH-HSIN YANG ; Chen Y.-M.; CHONG-JEN YU | Journal of Thoracic Oncology | 50 | 50 | |
56 | 2011 | Symptoms, psychological distress, and supportive care needs in lung cancer patients | Liao Y.-C.; WEI-YU LIAO ; Shun S.-C.; CHONG-JEN YU ; PAN-CHYR YANG ; YEUR-HUR LAI | Supportive Care in Cancer | 71 | 68 | |
57 | 2011 | Analysis of the paracrine loop between cancer cells and fibroblasts using a microfluidic chip | Hsu T.-H.; Xiao J.-L.; Tsao Y.-W.; Kao Y.-L.; Huang S.-H.; WEI-YU LIAO ; Lee C.-H. | Lab on a Chip | 46 | 45 | |
58 | 2011 | Using a three-chamber culture chip to study the interactions among cancer cells and two types of stromal cells | Lee C.-H.; Hsu T.-H.; Kao Y.-L.; Lin W.-L.; WEI-YU LIAO | 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011, MicroTAS 2011 | 0 | ||
59 | 2009 | Emphysematous gastritis: A deadly infectious disease | CHUN-TA HUANG ; WEI-YU LIAO | Scandinavian Journal of Infectious Diseases | 20 | 20 | |
60 | 2009 | Label-free quantification of asymmetric cancer-cell filopodium activities in a multi-gradient chip | Hsu T.-H.; Yen M.-H.; WEI-YU LIAO ; Cheng J.-Y.; Lee C.-H. | Lab on a Chip | 10 | 9 | |
61 | 2008 | TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer | CHAO-CHI HO ; WEI-YU LIAO ; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; HUEI-WEN CHEN ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 117 | 110 | |
62 | 2007 | Cancer cell filopodia characterized by super-resolution bright-field optical microscopy | Lee C.-H.; Hsu T.-H.; WEI-YU LIAO ; PAN-CHYR YANG ; Wang C.-C.; Xiao J.-L. | Conference on Lasers and Electro-Optics, 2007, CLEO 2007 | 0 | 0 | |
63 | 2007 | Cancer cell filopodia characterized by super-resolution bright-field optical microscopy | Lee C.-H.; Hsu T.-H.; WEI-YU LIAO ; PAN-CHYR YANG ; Wang C.-C.; Xiao J.-L. | Optics InfoBase Conference Papers | 0 | ||
64 | 2007 | Dynamics of cancer cell filopodia characterized by super-resolution bright-field optical microscopy | Hsu T.-H.; WEI-YU LIAO ; PAN-CHYR YANG ; Wang C.-C.; Xiao J.-L.; Lee C.-H. | Optics Express | 11 | 9 | |
65 | 2005 | Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells | Yao P.-L.; Lin Y.-C.; Wang C.-H.; Huang Y.-C.; WEI-YU LIAO ; Wang S.-S.; Chen J.J.W.; PAN-CHYR YANG | American Journal of Respiratory Cell and Molecular Biology | 39 | 35 | |
66 | 2005 | Global expression profiling of theophylline response genes in macrophages: Evidence of airway anti-inflammatory regulation | Yao P.-L.; Tsai M.-F.; Lin Y.-C.; Wang C.-H.; WEI-YU LIAO ; Chen J.J.W.; PAN-CHYR YANG | Respiratory Research | 22 | 20 | |
67 | 2004 | The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms | YIH-LEONG CHANG ; Lee Y.-C.; WEI-YU LIAO ; CHEN-TU WU | Lung Cancer | 89 | 61 | |
68 | 2004 | Testing the functional status model in patients with chronic obstructive pulmonary disease | Yeh M.-L.; Chen H.-H.; Liao Y.-C.; WEI-YU LIAO | Journal of Advanced Nursing | 32 | 24 | |
69 | 2004 | Value of imprint cytology for ultrasound-guided transthoracic core biopsy | WEI-YU LIAO ; JIH-SHUIN JERNG ; KUAN-YU CHEN ; YIH-LEONG CHANG ; PAN-CHYR YANG ; Kuo S.-H. | European Respiratory Journal | 21 | 18 | |
70 | 2002 | Pneumothorax in the ICU: Patient outcomes and prognostic factors | KUAN-YU CHEN ; JIH-SHUIN JERNG ; WEI-YU LIAO ; Ding L.-W.; LU-CHENG KUO ; JANN-YUAN WANG ; PAN-CHYR YANG | Chest | 62 | 60 | |
71 | 2000 | US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter | WEI-YU LIAO ; Chen M.-Z.; YIH-LEONG CHANG ; Wu H.-D.; CHONG-JEN YU ; Kuo P.-H.; PAN-CHYR YANG | Radiology | 79 | 73 | |
72 | 2000 | Bacteriology of infected cavitating lung tumor | WEI-YU LIAO ; Liaw Y.-S.; HAO-CHIEN WANG ; KUAN-YU CHEN ; KWEN-TAY LUH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 38 | 32 |